Wet AMD Treatment: How It Works, Results and What to Expect

Wet AMD treatment most often uses medicines injected into the eye to reduce abnormal blood vessel leakage and help preserve central vision. Treatment should begin promptly after diagnosis, because wet age-related macular degeneration can cause vision changes that worsen without care.

Overview: What Wet AMD Treatment Does

Wet age-related macular degeneration (wet AMD) is a condition affecting the macula, the central area of the retina responsible for detailed, straight-ahead vision. In wet AMD, abnormal blood vessels grow beneath or within the retina. These vessels can leak fluid or blood, which may quickly distort or reduce central vision.

The main wet AMD treatment is medication injected into the eye, usually an anti-vascular endothelial growth factor (anti-VEGF) medicine. It reduces signals that promote abnormal blood vessel growth and leakage. Although treatment cannot restore retinal tissue already permanently damaged, it can often dry retinal fluid, slow or stop further vision loss, and sometimes improve vision.

People may encounter broad online searches such as “wet WebMD” when looking for information. Reliable guidance should still be individualized by an ophthalmologist, because the scan findings, vision in each eye, other eye conditions and response to treatment all influence the care plan.

How Quickly Does Wet AMD Need to Be Treated?

Wet AMD needs prompt specialist assessment. A sudden change in central vision, new wavy or bent lines, a blurred or missing area, reduced color brightness, or difficulty recognizing faces may indicate active leakage or bleeding. These symptoms should not be watched at home for several days; an eye doctor or urgent eye service should be contacted as soon as possible.

The question “how quickly does wet AMD need to be treated?” does not have one exact number of days for every person. However, earlier diagnosis and treatment generally provide the best opportunity to preserve remaining vision. Once wet AMD is confirmed, the ophthalmology team will usually discuss treatment without unnecessary delay.

Wet AMD can affect one eye first, while the other eye may remain at risk. Monitoring each eye separately is important because vision in the stronger eye can sometimes mask early changes in the other eye.

How Anti-VEGF Eye Injections Work

Anti-VEGF medicines block VEGF, a natural signaling protein that can encourage the formation and leakage of abnormal retinal blood vessels in wet AMD. By reducing VEGF activity, these medicines can decrease swelling and fluid in or under the retina. Retinal scans often show whether the macula is becoming drier after treatment.

Several anti-VEGF medicines may be appropriate. The choice depends on factors such as retinal imaging results, prior response, treatment interval, medical history and availability. In selected situations, other approaches may be considered, but injections remain the standard first-line treatment for most people with active wet AMD.

The treatment of wet AMD is usually ongoing rather than a one-time procedure. The eye may appear stable after injections, but disease activity can return if medication is stopped too early. Regular follow-up helps the specialist identify recurrence before it causes more noticeable visual loss.

A typical wet treatment protocol starts with close follow-up and injections at planned intervals. Later, some people continue on fixed intervals, while others follow a “treat-and-extend” approach, in which intervals may gradually lengthen if scans remain stable. The protocol is adjusted to the individual eye rather than following a single schedule for everyone.

Who May Be a Candidate and How Wet AMD Is Diagnosed

A person may be considered for treatment when examination and imaging show active wet AMD, such as fluid, bleeding or abnormal blood vessels affecting the macula. Symptoms are important, but imaging can identify activity even when changes in vision are subtle. An ophthalmologist, often a retina specialist, will assess both eyes.

Diagnosis commonly includes a dilated eye examination and optical coherence tomography (OCT), a noninvasive scan that creates detailed cross-sectional images of the retina. Some people also need fluorescein angiography or other retinal imaging to clarify the type and location of abnormal vessels.

Age is the strongest risk factor for AMD. Smoking, family history, cardiovascular risk factors and having advanced AMD in the other eye can also increase risk. Dry AMD can progress to wet AMD, but not everyone with dry AMD develops the wet form.

Before injection treatment, the eye team reviews allergies, previous eye procedures, current medicines and any signs of an eye infection. An active infection around or inside the eye may mean that treatment should be postponed until it is safe to proceed.

What Happens During the Procedure

Intravitreal injection treatment is usually performed as an outpatient procedure. The eye is cleaned carefully to lower infection risk, and anesthetic drops or gel are used to numb the surface of the eye. The eyelids may be gently held open with a small instrument.

The medication is then injected through the white part of the eye, called the sclera, using a very fine needle. The injection itself is brief. Most people describe pressure, mild discomfort or awareness of the procedure rather than significant pain, although experiences vary.

Afterward, the clinician may check vision or eye pressure and explain what symptoms to monitor. The pupil may remain dilated for a short time if dilating drops were used at the appointment. Someone else may be helpful for transport home when vision is blurred.

Patients should follow the specific instructions provided by their eye team. The eye should not be rubbed after the injection, and any prescribed drops or follow-up appointments should be used exactly as advised.

Benefits, Risks and Expected Results

The central benefit of wet AMD treatment is reducing the risk of further vision loss from active leakage. Many people maintain vision with consistent treatment, and some notice sharper or less distorted vision as fluid reduces. The degree of improvement depends on how much retinal damage was present before treatment and how the eye responds over time.

Short-term effects can include a scratchy sensation, tearing, mild redness on the white of the eye, floaters or temporary blurred vision. A small red patch caused by a surface blood vessel can look concerning but commonly resolves gradually. The care team can advise which symptoms are expected in an individual case.

Serious complications are uncommon but require urgent assessment. These include infection inside the eye, retinal tear or detachment, significant bleeding, a severe rise in eye pressure, or inflammation. Severe or increasing eye pain, worsening redness, light sensitivity, a marked drop in vision, increasing floaters, flashes of light, or a curtain-like shadow should be reported immediately.

Not every eye responds equally, and some people need more frequent treatment than others. The ophthalmologist uses vision testing and OCT scans to determine whether the medicine is controlling activity and whether the plan should change.

Recovery, Monitoring and Everyday Self-Care

Most people return to usual light activities the day after an injection, provided their eye team has not given different instructions. Mild irritation or temporary blur often settles within a day or two. It is sensible to avoid rubbing the treated eye and to use clean hands before touching the area around it.

Follow-up is a key part of recovery because wet AMD can reactivate without dramatic symptoms. At visits, the clinician checks vision and reviews OCT images for fluid or other signs of activity. Keeping injection and scan appointments is one of the most important steps a person can take to protect vision.

At home, an Amsler grid or similar clinician-recommended method may help a person notice new line distortion or missing areas in central vision. It does not replace scheduled monitoring. Each eye should be checked separately, because symptoms in one eye can be missed when both eyes are open.

Stopping smoking, managing blood pressure and cholesterol with a healthcare professional, eating a balanced diet and protecting eyes from excessive sunlight are sensible general measures for eye and vascular health. Nutritional supplements may be appropriate for certain stages of dry AMD, but they do not replace anti-VEGF therapy for active wet AMD and should be discussed with an eye specialist.

When to Seek Medical Care

New or sudden central vision changes deserve urgent medical attention. This includes straight lines appearing wavy, new blur, a gray or dark central spot, rapid decline in reading vision, new difficulty recognizing faces, or a noticeable difference between the two eyes. Prompt evaluation is especially important for people who have AMD in the other eye.

After an eye injection, contact the treating clinic urgently if there is increasing pain, worsening redness, discharge, sensitivity to light, substantial reduction in vision, or a growing number of floaters. Emergency assessment is also needed for flashes or a dark curtain in the field of vision.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients requiring assessment and treatment for retinal conditions, with care plans guided by ophthalmic examination and imaging.

Frequently asked questions

Can wet AMD be cured?

Wet AMD cannot currently be cured, and treatment cannot reverse all retinal damage that has already occurred. However, anti-VEGF treatment can control abnormal vessel leakage and often helps preserve vision. Some people also experience improvement in vision.

How often are wet AMD injections needed?

Injection frequency varies by medicine, scan findings and individual response. Treatment may begin with visits close together, followed by fixed or personalized intervals. Ongoing monitoring is needed because wet AMD activity can return.

Do wet AMD injections hurt?

The eye is numbed before the procedure, so most people feel brief pressure or mild discomfort rather than sharp pain. A scratchy sensation or mild irritation afterward can occur. Severe or increasing pain is not expected and should be reported promptly.

What happens if wet AMD is left untreated?

Active wet AMD can lead to further central vision loss because leaking or bleeding blood vessels can damage the macula. The speed of progression varies, but timely assessment and treatment offer the best chance of limiting additional damage. Peripheral vision is usually affected differently from central vision.

Can lifestyle changes replace wet AMD treatment?

Lifestyle measures such as not smoking and managing cardiovascular health can support overall eye health, but they do not replace treatment for active wet AMD. Anti-VEGF injections directly address abnormal blood vessel leakage. An ophthalmologist can advise on both treatment and risk reduction.

Will I need treatment in both eyes?

Wet AMD may affect one or both eyes, but each eye is assessed and treated separately. If the second eye develops active disease, it may also need treatment. Regular monitoring is important even when only one eye is currently receiving injections.

References

• American Academy of Ophthalmology
• National Eye Institute
• National Health Service
• Macular Society
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.